Six Sigma Approach for a First Evaluation of a Pharmacological Therapy in Tongue Cancer

Tongue cancers are among the most frequent malignancies in the population and their influence can be affected by many risk factors. Patients undergoing tongue surgery face different complications and can experience a long length of hospital stay (LOS). The aim of this paper is to compare two pharmacological therapies in order to understand which one decreases the LOS. At the University hospital of Naples “Federico II” two antibiotics were employed: Cefazolin plus Clindamycin and Ceftriaxone. Six Sigma methodology was employed to analyse two group of patients treated with these two different antibiotics: 55 patients treated with the antibiotic Cefazolin plus Clindamycin and 66 patients with the antibiotic Ceftriaxone. This is the first time that this methodology is used in order to compare two antibiotics in the oncology field. The results obtained show clearly and with a statistical evidence that patients treated with Ceftriaxone experienced a lower LOS (−28.6% in terms of percentage between medians). Reducing the LOS for patients means limiting the number of complications and, therefore, reducing the hospitalization costs. It would be valuable for both hospital and patients: the former would save money that they could invest in other important care activities; the latter would experience a higher quality of care with fewer complications.